Jaume Veciana, Scientific Director of NANBIOSIS; Director of Molecular Nanosciences and Organic Materials Dpt. (ICMAB-CSIC) and Coordinator of Platform Programme of CIBER BBN.
Francisco Miguel Sánchez Margallo; Assistant Director of NANBIOSIS and Scientific Director of JUMISC
Ramón Martínez Máñez, Scientific Director of CIBER-BBNPI of the Group of Applied Molecular Chemistry Center of Molecular Recognition and Technological Development of the Polytechnic University of Valencia (UPV-ADM-IQMA) Scientific Director of NANBIOSIS Unit 26
María Luisa García Martín, Scientific Director of NANBIOSIS Unit 28, PI of the Group Biomedical Magnetic Resonance Laboratory-BIONAND,
Pablo Laguna, Scientific Director of NANBIOSIS Unit 27, PI of the Biomedical Signal Interpretation and Computational Simulation (BSICoS) group; Scientific Coordinator of I3A (Aragon Institute of Engineering Research)
Verónica Crisóstomo, Researcher at the Endoluminal Diagnostic and Therapeutic Unit of the Minimally Invasive Surgery Center Jesús Usón.
Nerea Argárate; Coordinator of NANBIOSIS. Responsible for Infrastructures and Research Services of CIBER BBN.
Raquel Ruiz Hidalgo; Deputy Coordinator of NANBIOSIS; R&D&i Coordinator of JUMISC.
Scientific-Technical Advisory Board
Pilar Calvo, Pharmaceutical Development Manager of PHARMAMAR
Anton Ussi, Operations and Finance director at EATRIS ERIC, the European Infrastructure for Translational Medicine, Amsterdam, The Netherlands
Ruth Schmid. Vicepresident SINTEF, Norway
Jürguen Borlak, Director of Institute for Pharmaco- and Toxicogenomics, Hannover Medical School, Germany
Begoña Castro, Scientific Director of Histocell, Madrid
Stefania Raimondo, Professor of the University of Turin, Italy
Anna Bigas, Scientific Director o CIBERONC and researcher at IMIM
Ignacio Santiago Álvarez, Professor of the University of Extremadura / Scientific Director IERA-GC, Badajoz
Joaquin Arribas, Director of Preclinical Research VHIO and Head of the Growth Factors Laboratory, Barcelona
Francisco Fernández Avilés, Chair of the Department of Cardiology, University Hospital Gregorio Marañón, Madrid
Antonio Bernad, Research Proffessor at Immunology and Onocology Department, National Center for Biotechnology (CNB), Madrid
Pedro Pesini, Senior Manager, Scientific Affairs en Araclon Biotech-Grifols
Access Committee
Stefania Raimondo, Professor of the University of Turin, Italy
Mª Eugenia Fernández Santos, Director of Advanced Therapy Medicinal Products Production Unit and Regenerative Medicine-GMP facilities of Gregorio Marañón Hospital, Madrid
Javier García Casado, Associate Professor in the University of Extremadura, Cáceres, Spain
